PainReform Stock Quote PRFX - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
PainReform Ltd (PRFX) Quote

PainReform Ltd (PRFX)

2.95

-0.21

( -6.65% )

Updated: 13:46:36

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

2.95

Bid

2.90

Ask

3.00

Volume

207,157

2.8802 Day's Range 3.24

0.4318 52 Week Range 20.16

Market Cap

Previous Close

3.16

Open

2.95

Last Trade

Last Trade Time

13:46:44

Financial Volume

$ 621,171

VWAP

2.9986

Average Volume (3m)

3,812,920

Shares Outstanding

1,171,041

Dividend Yield

-

PE Ratio

-0.36

Earnings Per Share (EPS)

-7.98

Revenue

-

Net Profit

-9.34M

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.painreform.com

Headquarters

Herzliya, Center, Isr

Founded

-

PainReform Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRFX. The last closing price for PainReform was $3.16. Over the last year, PainReform shares have traded in a share price range of $ 0.4318 to $ 20.16.

PainReform currently has 1,171,041 shares outstanding. The market capitalization of PainReform is $3.70 million. PainReform has a price to earnings ratio (PE ratio) of -0.36.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

TEL AVIV, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

This notification has no immediate effect on the listing or trading of PainReform’s ordinary shares on the Nasdaq Capital Market TEL AVIV, Israel, Nov. 07, 2024 (GLOBE NEWSWIRE) -- PainReform...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.26	9.66542750929	2.69	3.3299	2.51	1214819	2.82232439	CS
4	2.5058	564.115263395	0.4442	3.9	0.44	10431136	1.43914845	CS
12	1.34	83.2298136646	1.61	3.9	0.4318	3812920	1.38300121	CS
26	-1.31	-30.7511737089	4.26	4.8	0.4318	2400799	1.49302521	CS
52	-12.65	-81.0897435897	15.6	20.16	0.4318	1257575	1.75520684	CS
156	-99.05	-97.1078431373	102	158.46	0.4318	583318	17.04696423	CS
260	-397.25	-99.2628685657	400.2	470.4	0.4318	569472	72.68574463	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTNTCheetah Net Supply Chain Service Inc	$ 5.24 (180.21%)	107.44M
ZJKZJK Industrial Company Ltd	$ 14.68 (131.55%)	20.43M
GWAVGreenwave Technology Solutions Inc	$ 0.6048 (65.70%)	399.39M
JYDJayud Global Logistics Ltd	$ 1.0792 (61.05%)	9.35M
JANXJanux Therapeutics Inc	$ 62.185 (54.77%)	5.28M
REVBRevelation Biosciences Inc	$ 0.5532 (-41.76%)	3.83M
OMEXOdyssey Marine Exploration Inc	$ 0.4752 (-36.23%)	3.53M
STSSSharps Technology Inc	$ 2.235 (-33.36%)	377.67k
CYCNCyclerion Therapeutics Inc	$ 1.61 (-31.20%)	266.25k
GELSGelteq Ltd	$ 2.703 (-29.25%)	224.97k
GWAVGreenwave Technology Solutions Inc	$ 0.6048 (65.70%)	399.45M
SMCISuper Micro Computer Inc	$ 40.86 (-2.71%)	169.47M
CTNTCheetah Net Supply Chain Service Inc	$ 5.24 (180.21%)	108.99M
CHRSCoherus BioSciences Inc	$ 1.88 (37.23%)	102.71M
NVDANVIDIA Corporation	$ 138.9509 (0.23%)	101.13M

tw0122

tw0122 1 day ago

$3.14 +10% Phase 3 looks ok. Some ambiguity still on post result treatment but if you error on the slightly positive side for resultsva 500% gainer with the 500k float

glenn1919

glenn1919 4 days ago

PRFX..............................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 1 week ago

PRFX......................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 1 week ago

PRFX........................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

benyam

benyam 2 weeks ago

where the hell all share s came from if reverse stock split will happen and outstanding share will bbee less pne one milly available

glenn1919

glenn1919 2 weeks ago

PRFX.................................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

subslover

subslover 2 weeks ago

PainReform Ltd. (the “Company”) is announcing that it will effect a reverse share split of the Company’s ordinary shares after market close on Wednesday, November 20, 2024, at the ratio of 1-for-4, such that each four (4) ordinary shares, no par value, shall be consolidated into one (1) ordinary share, no par value. The first date when the Company’s ordinary shares will begin trading on the Nasdaq Capital Market after implementation of the reverse split will be Thursday, November 21, 2024.

Following the implementation of the reverse split, the Company’s authorized share capital shall be comprised of 2,500,000 ordinary shares, no par value per share, and approximately 590,616 ordinary shares shall be issued and outstanding.

No fractional ordinary shares will be issued as a result of the reverse split. All fractional ordinary shares will be rounded up to the nearest whole ordinary share. In addition, a proportionate adjustment will be made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase ordinary shares.

tw0122

tw0122 2 weeks ago

$1.78 + 230% lock profits in the )1.76- $2.02 zone next zone is $2.29- $2.48

tw0122

tw0122 2 weeks ago

Ok still going $1.49 + 178%

Tool_power

Tool_power 1 month ago

They’re doing another reverse split… 4:1 this time. Ridiculous! Horrible management.

TheFinalCD

TheFinalCD 1 month ago

https://x.com/READY_2_PROFIT/status/1848715094986772787

Monksdream

Monksdream 2 months ago

PRFX new 52 week low

Monksdream

Monksdream 2 months ago

PRFX new 52 week low

tw0122

tw0122 3 months ago

New reoffering couldn’t sell shares first time nor on new reduced price take it to
20 cents and do another reverse split. Bye bye shareholders this is the penny bio scam game

Awl416

Awl416 3 months ago

Awl416

Awl416 3 months ago

I would fall for it

Surfacetite

Surfacetite 3 months ago

Snagged some. Good pr

Awl416

Awl416 3 months ago

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

glenn1919

glenn1919 3 months ago

PRFX...............................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

Awl416

Awl416 3 months ago

That chart. Yikes…

it_happens

it_happens 3 months ago

Moving up nicely today

it_happens

it_happens 3 months ago

Doesn't look like it today

Surfacetite

Surfacetite 3 months ago

Can we break $1 again.

TheFinalCD

TheFinalCD 3 months ago

its much better to trade the front side of these runs, than trying to catch a dip and rip

otherwise you can get caught in one of these all day chop & grind, lower lows, Gap & Traps like PRFX

Ive learned too many le$$ons the hard way

Tool_power

Tool_power 3 months ago

stock1ace1

stock1ace1 3 months ago

Invest-in-America

Invest-in-America 3 months ago

PRFX: Hey, Bro, the ONLY "PainReform" this Israel company must engage is the termination of the Hitler-like SLAUGHTER of patently-innocent Arabic kids, adults, seniors, & their pet cats & dogs.

Tool_power

Tool_power 3 months ago

Catching a bid @ .33

madras50

madras50 3 months ago

Awl416

Awl416 3 months ago

TheFinalCD

TheFinalCD 3 months ago

glenn1919

glenn1919 3 months ago

PRFX.................................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

Invest-in-America

Invest-in-America 3 months ago

PRFX: Its ISRAEL headquarters ruined this!!! (FUCK that damn nation!!)

tw0122

tw0122 3 months ago

Printing dilution shares faster then the Federal Reserve prints cash . They are Gangsta

TrendTrade2016

TrendTrade2016 3 months ago

incoming attack from enemy drones....

it_happens

it_happens 3 months ago

Kind of like a yoyo this morning. Think it will go back up?

TheFinalCD

TheFinalCD 3 months ago

TOOK SOME .59'S HPW BOUT U

TrendTrade2016

TrendTrade2016 3 months ago

dilution up...cash down...warrants and s-1s galore~!

tw0122

tw0122 3 months ago

TrendTrade2016

TrendTrade2016 3 months ago

ouch...dilution brings it down fast

TheFinalCD

TheFinalCD 3 months ago

1.17 -.64 IS RUDE

Awl416

Awl416 3 months ago

TheFinalCD

TheFinalCD 3 months ago

tw0122

tw0122 3 months ago

Join the hedgies lol .95 + 200%

TheFinalCD

TheFinalCD 3 months ago

https://healthstockshub.com/news/nyseamex/igc/igc-pharma-expands-drug-portfolio-to-metabolic-disorders-with-igc-1a-a-potential-new-glp-1-agonist

https://dilutiontracker.com/app/search/PRFX?a=dbb88c

Awl416

Awl416 3 months ago

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

Monksdream

Monksdream 4 months ago

PRFX new 52 week low

Monksdream

Monksdream 4 months ago

PRFX new 52 week low

FALCON1

FALCON1 4 months ago

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

Sirpeter

Sirpeter 4 months ago

I'm out again...was too early...it will have its day by Y/E

iShares MSCI India Small...

Btp Tf 4,45% St43 Eur

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions